Skip to content
Search

Latest Stories

Supply chain issues and staff shortage increasing pressure on community pharmacies

Majority of the pharmacies are facing aggression from patients due to the medicine supply chain issue, a PSNC survey has revealed.

The Pharmacy Pressures Survey by the trade body has seen nearly 83 per cent of pharmacies reporting a significant increase in medicine supply issues in the past year, leading to extra work and additional stress for staff.


The survey of over 5,000 pharmacy premises and 1,000 pharmacy team members in England took place in early 2022.

Two-thirds of respondents said that medicines supply chain issues are a daily occurrence, with 97 per cent reporting that this led to frustration from patients.

“The results of PSNC’s Pressures Survey make distressing reading for anybody in the sector – they tell a story of teams under immense pressures, and of businesses at crisis point," said Janet Morrison, PSNC chief executive.

"Pharmacy teams will do everything to ensure that patients get what they need, so it is particularly worrying to see the impact that pressures are starting to have on patients and the public as well.

"We must take these findings as the warning signal that they are: the pressures on community pharmacies – coming from a combination of workload, workforce and financial factors – are simply unreasonable, and unsustainable."

The daily occurrence of medicine shortage has become a major concern for pharmacies. According to the survey report, pharmacy teams spend many hours trying to resolve these supply issues so that patients are not affected by them, with the average time spent by pharmacy teams being 5.3 hours per week.

Almost all pharmacies experience extra workload and stress due to supply issues, and patients are frustrated and inconvenienced by the supply issues: 75 per cent of pharmacies reported experiencing aggression from patients due to medicine supply issues.

Staff shortage is another issue that is adding to the pressure on community pharmacies, the survey results indicated that that 91 per cent of pharmacies are experiencing staff shortages and almost half of contractors are extremely concerned about their pharmacy’s finances, with 80 per cent reporting that the costs to run their pharmacies are significantly higher when compared to a year ago. At the same time, nine out of ten pharmacy teams have seen a significant increase in phone calls from patients about prescriptions, and 86 per cent reported a rise in requests for healthcare advice.

With pharmacies under this level of workload pressure, PSNC also heard about the impact on the mental health and wellbeing of pharmacy staff. The survey found that:

  • 98% of respondents said that workforce shortages are resulting in increased pressure on pharmacy teams;
  • 82% said that increased workplace pressures are negatively affecting their mental health and wellbeing; and
  • On a scale of 1 – 10, where 1 is not coping at all and 10 is coping perfectly fine, 79% of respondents scored their team as 5 or below.

As a consequence, two-thirds of pharmacies have had to cut back on services or the advice they offer to patients, and 29 per cent have had to reduce their opening hours. These are last resort measures that are limiting pharmacy staff’s ability to spend the time with patients that they want to, and making them uncertain of their capacity to take on new services in the future.

In the survey:

  • 90% of pharmacies reported that they are unable to spend as much time with their patients;
  • 87% said prescriptions now take longer to dispense; and
  • Only 34% of respondents said that they felt that they had some capacity to take on new services in future.

PSNC said that these pressures are a key focus in the ongoing Year 4 CPCF negotiations.

"Millions of people rely on their local pharmacies every day, and it is imperative both for them and for the wider NHS that this does not fail: to guard against that, NHS England and the government must take heed of these findings and work with us to urgently address the causes. Without this extra support, patients and the public can expect to see an end to some of the pharmacy services that they have come to know and value," said Morrison.

"PSNC has highlighted these findings to NHSE&I and the government, and we will continue to press them to give the sector the additional support it needs. Thank you to everyone who completed our Pressures Survey and in doing so helped to strengthen our case.”

Commenting on the Pharmacy Pressures Survey NPA Chair Andrew Lane, “Pharmacies are struggling under relentless workload, staff shortages and spiralling costs. They are determined not to let patients down, but there is only so much pressure anyone can withstand – whether that be individual pharmacists, a team or pharmacy businesses.

“In recent years, expectations have grown about what community pharmacies can deliver, but investment by government and the NHS in England hasn’t kept pace. That’s the context for these depressing survey results. These survey results reflect what we hear consistently from the independent pharmacies we represent – so they are shocking but not in the least bit surprising, unfortunately.”

Expressing the concern over staff shortage, Malcolm Harrison, Chief Executive of the Company Chemists’ Association (CCA) commented, “This confirms our existing concerns about there being a workforce crisis in community pharmacy. Earlier this year, the CCA uncovered a shortfall of 3,000 community pharmacists in England and the recent Health Education England (HEE) workforce survey highlights rising vacancies amongst the entire pharmacy team. We urgently need the Government to recognise these workforce pressures and devise an evidence-led workforce plan for all of primary care”.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less